Melanotan II (MTII)

Melanotan II (MTII, Melanotan 2) is a synthetic analogue of α-melanocyte-stimulating hormone (α-MSH) and is widely used as a research compound in studies of the melanocortin receptor system. MTII acts on melanocortin receptors, including MC1R, MC3R, and MC4R, and has been investigated for its effects on pigmentation and a range of melanocortin-mediated physiological processes.

As a melanocortin receptor agonist, MTII is commonly used to investigate melanogenesis, pigmentation, melanocortin signaling, energy metabolism, appetite regulation, and related physiological mechanisms. Its activity across multiple melanocortin receptor subtypes makes it a useful research tool for studying melanocortin receptor signaling and downstream biological responses.

MTII may be used as a research material in pharmacology, receptor biology, melanocortin pathway research, and metabolic studies. Its biological effects may vary depending on the receptor subtype, experimental model, and study conditions.

Product Information:

  • Name: Melanotan II
  • Abbreviation: MTII / MT-2
  • Type: Synthetic peptide / melanocortin receptor research agonist
  • Primary Targets: Melanocortin receptors, including MC1R, MC3R, and MC4R
  • Research Areas: Melanogenesis, pigmentation, melanocortin signaling, energy metabolism, appetite regulation, and related physiological processes
  • Application: Pharmacological and basic research
  • Status: Investigational research compound; not an approved marketed drug

Research Use Only